- 2 updates
Professor Peter Barrett-Lee is the Medical director at Velindre Cancer Centre. A new drug Kadcyla is available for patients to use today. At the moment it can only be used to prolong the life of suffers in the later stages of breast-cancer.
But Professor Peter Barrett-Lee says in the future, the drug could be further developed 'to cure breast cancer.'
A new breast cancer drug, trialled in Cardiff, is now available for patients to use.
Kadcyla can add up to six months onto the lives of some sufferers and reduce some of the side-effects associated with standard chemotherapy.
The drug, which is only suitable for breast cancer patients with a defective Her2 gene, destroys cancer cells from within.
It means the side-effects associated with usual chemotherapy are reduced, i.e. hair loss, severe diarrhoea and fatigue.
Fewer side-effects can mean that patients are able to have a better quality of life.